2633.HK · JACOBSON PHARMA
Hong Kong · RS rating 41 · As of 2026-10-14
| Price | 0.96 HKD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 59 / 40 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 17 / 33 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +35.6% |
| Market cap (USD) | $247.2M |